niacinamide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 9 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Fathi, M | 1 |
| Vakili, K | 1 |
| Yaghoobpoor, S | 1 |
| Tavasol, A | 1 |
| Jazi, K | 1 |
| Hajibeygi, R | 1 |
| Shool, S | 1 |
| Sodeifian, F | 1 |
| Klegeris, A | 1 |
| McElhinney, A | 1 |
| Tavirani, MR | 1 |
| Sayehmiri, F | 1 |
| Whittaker, DS | 1 |
| Wang, HB | 1 |
| Loh, DH | 1 |
| Cachope, R | 1 |
| Colwell, CS | 1 |
| Sidhu, A | 1 |
| Diwan, V | 1 |
| Kaur, H | 1 |
| Bhateja, D | 1 |
| Singh, CK | 1 |
| Sharma, S | 1 |
| Padi, SSV | 1 |
| Naia, L | 1 |
| Rosenstock, TR | 1 |
| Oliveira, AM | 1 |
| Oliveira-Sousa, SI | 1 |
| Caldeira, GL | 1 |
| Carmo, C | 1 |
| Laço, MN | 1 |
| Hayden, MR | 1 |
| Oliveira, CR | 1 |
| Rego, AC | 1 |
| Hathorn, T | 1 |
| Snyder-Keller, A | 1 |
| Messer, A | 1 |
| Sorolla, MA | 1 |
| Nierga, C | 1 |
| Rodríguez-Colman, MJ | 1 |
| Reverter-Branchat, G | 1 |
| Arenas, A | 1 |
| Tamarit, J | 1 |
| Ros, J | 1 |
| Cabiscol, E | 1 |
| Sheline, CT | 1 |
| Zhu, J | 1 |
| Zhang, W | 1 |
| Shi, C | 1 |
| Cai, AL | 1 |
| Beal, MF | 1 |
| Hankes, LV | 1 |
| Coenen, HH | 1 |
| Rota, E | 1 |
| Langen, KJ | 1 |
| Herzog, H | 1 |
| Wutz, W | 1 |
| Stoecklin, G | 1 |
| Feinendegen, LE | 1 |
2 reviews available for niacinamide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleac | 2022 |
Neurochemistry and toxin models in Huntington's disease.
Topics: Animals; Coenzymes; Disease Models, Animal; Energy Metabolism; Humans; Huntington Disease; Mitochond | 1994 |
7 other studies available for niacinamide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.
Topics: Animals; Benzazepines; Cognition; Disease Models, Animal; Drug Administration Schedule; Histamine H3 | 2017 |
Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.
Topics: Animals; Dose-Response Relationship, Drug; Huntington Disease; Male; Neuroprotection; Niacinamide; N | 2018 |
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.
Topics: Animals; Corpus Striatum; Disease Models, Animal; DNA, Mitochondrial; Humans; Huntington Disease; Me | 2017 |
Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease.
Topics: Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Humans; Huntington Disea | 2011 |
Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.
Topics: Humans; Huntington Disease; Mutant Proteins; Mutation; Niacinamide; Oxidative Stress; Peptides; Sacc | 2011 |
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; | 2013 |
Effect of Huntington's and Alzheimer's diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain; Humans; Huntington Disease; Niacin; Niacinamide; Tomo | 1991 |